18:50 - 20:15
Qol-P
Quality of Life | Poster Session B
Qol-P-01
Interviews with patients and their spouses to capture personal descriptions of early treatment experience with mogamulizumab for Mycosis fungoides (MF) and Sézary syndrome (SS)
Poster
Jane Gibson
(The Christie NHS Foundation Trust, Manchester, United Kingdom)
Qol-P-02
Psychological aspects and coping strategies in patients with mycosis fungoides
Poster
Shamir Geller
(Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel)
 
Qol-P-03
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a review of the literature
Poster
Rosanne Ottevanger
(Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands)
Qol-P-04
Health-related Quality of Life Effect of Mogamulizumab by Patient Blood Involvement
Poster
Pablo Ortiz-Romero
(Department of Dermatology, University Complutense, Hospital 12 de Octubre, Medical School, Institute i+12, Madrid, Spain)
Qol-P-05
A Cross-Sectional Study Examining the Diagnosis and Psychosocial Experiences of Patients with Cutaneous Lymphomas
Poster
Susan Thornton
(Management, Cutaneous Lymphoma Foundation, Birmingham, MI, United States)
Qol-P-06
Assessing quality of life with ePROMs in patients with cutaneous lymphoma
Poster
Georgia Jane Crooks
(Manchester Medical School-The Christie Hospital, Manchester, United Kingdom)